Clinical trial
LYT-100 in Patients With BCRL
NCT04243837
Study timeline
Study start (actual)2020-03-01Date precision: day
Registry last updated2024-04-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancer Related Lymphoedemaunresolved
Lymphoedemaunresolved
Interventions
LYT-100 BCRLDRUG
Placebo BCRLDRUG
Sponsors & collaborators
PureTechlead sponsor
Novotech (Australia) Pty Limitedcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04243837 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.